Announcement

[Economic Today Reporter Byungho Jang] The medical temperature control device MCD (Medical Chilling Device) developed by the NHI New Hair Hair Transplant Center has been commercialized and applied to actual hair transplant surgery.
MCD, a medical temperature control device, keeps the hair follicle at 4℃ during the hair transplant process until it is planted at the transplant site, preventing the hair follicle from evaporating from moisture and from damage due to high heat.
The success indicator of hair transplantation is based on how long the transplanted hair has grown. This is called the so-called engraftment rate, and it seems to be an opportunity to obtain a higher engraftment rate by preserving the hair follicle cells to be transplanted at the most complete temperature of 4°C.

In hair transplant surgery, the rate of engraftment of hair follicles greatly affects the outcome of the surgery. In particular, the hair follicle cells must be kept at a low temperature of 4℃ to increase the engraftment rate of transplanted hair. Therefore, in the meantime, maintaining the temperature of the hair transplant is the most important.
To increase the rate of engraftment of hair follicle cells, medical staff have placed ice in a small plastic container and stored the collected hair follicle cells in a clear glass dish containing physiological saline. However, since these methods have to rely on ice or refrigerant, it has been difficult to consistently obtain the same temperature.
Kim Jin-oh, director of the NHI New Hair Hair Transplant Center, said, “First of all, you can find great significance of this development in that it can maintain 4℃ that never changes until the surgery is finished.”
“Maintaining 4℃ is not everything to a successful hair transplant, but if even one more hair can grow, it will be a valuable attempt for hair loss patients.”